The genomics revolution: Relevance in healthcare today and tomorrow

Journal of the Royal College of Physicians of Edinburgh

Volumn 42, Issue 3, 2012, Pages 248-250

  Brown, C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME DISORDER; CLINICAL PRACTICE; CLINICAL RESEARCH; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISORDER; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; HEALTH CARE; HEALTH CARE QUALITY; HUMAN; HUNTINGTON CHOREA; KARYOTYPE; MEDICAL ETHICS; PHARMACOGENOMICS; PHENOTYPE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SINGLE NUCLEOTIDE POLYMORPHISM;

DELIVERY OF HEALTH CARE; EPILEPSY; GENOMICS; HUMANS; HUNTINGTON DISEASE; LEARNING DISORDERS;

EID: 84873855189     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2012.313     Document Type: Article

References (15)

1. House of Lords Science and Technology Committee. Genomic medicine; 2nd report of session 2008-2009. London: House of Lords; 2009.
2. Tarpey PS, Smith R, Pleasance E et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 2009; 41:535-43. http://dx.doi.org/10.1038/ ng.367
3. Willatt L, Cox J, Barber J et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 2005; 77:154-60. http://dx.doi.org/10.1086/431653
4. Goobie S, Knijnenburg J, Fitzpatrick D et al. Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting. Cytogenet Genome Res 2008; 123:65-78. http://dx.doi.org/10.1159/000184693
5. National Institute for Clinical Excellence. National clinical audit of epilepsy-related death [Internet]. London: NICE; 2002 [cited 2012 jun 21]. Available from: http://www.nice.org.uk/media/94E/3C/ epilepsyreport.pdf
6. Zuberi SM. Chromosome disorders associated with epileptic seizures. In: Panayiotopoulos CP, Benbadis SR, Beran RG et al, editors. Atlas of epilepsies. Springer 2010. pp.121-7. http://dx.doi. org/10.1007/978-1-84882-128-6_17
7. Depienne C, Trouillard O, Saint-Martin C et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 2009; 46:183-91. http://dx.doi. org/10.1136/jmg.2008.062323
8. Heron SE, Cox K, Grinton BE et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet 2007; 44:791-6. http://dx.doi.org/10.1136/jmg.2007.051938
9. Deprez L, Weckhuysen S, Holmgren P et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology 2010; 75:1159-65. http://dx.doi.org/10.1212/ WNL.0b013e3181f4d7bf
10. Chiron C, Marchand MC, Tran A et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000; 356:1638-42. http://dx.doi.org/10.1016/S0140-6736(00)03157-3
11. Konstantinidou A, Fryssira H, Sifakis S et al. Cranioectodermal dysplasia: a probable ciliopathy. Am J Med Genet A 2009;149A:2206-11. http://dx.doi.org/10.1002/ajmg.a.33013
12. Vissers LE, de Ligt J, Gilissen C et al. A de novo paradigm for mental retardation. Nat Genet 2010; 42:1109-12. http://dx.doi. org/10.1038/ng.712
13. Davies EC, Green CF, Taylor S et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient episodes. PLoS One 2009; 4:e4439. http://dx.doi.org/10.1371/ journal.pone.0004439
14. Hughes DA, Vilar FJ, Ward CC et al. Cost-effective analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics 2004; 14:335-42. http://dx.doi.org/10.1097/00008571-200406000-00002
15. Mallal S, Phillips E, Carosi G et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358:568-79. http:// dx.doi.org/10.1056/NEJMoa070613571-200406000-00002